[HTML][HTML] Phenotypic miRNA screen identifies miR-26b to promote the growth and survival of endothelial cells

A Martello, D Mellis, M Meloni, A Howarth… - … Therapy-Nucleic Acids, 2018 - cell.com
A Martello, D Mellis, M Meloni, A Howarth, D Ebner, A Caporali, AAH Zen
Molecular Therapy-Nucleic Acids, 2018cell.com
Endothelial cell (EC) proliferation is a crucial event in physiological and pathological
angiogenesis. MicroRNAs (miRNAs) have emerged as important modulators of the
angiogenic switch. Here we conducted high-content screening of a human miRNA mimic
library to identify novel regulators of EC growth systematically. Several miRNAs were
nominated that enhanced or inhibited EC growth. Of these, we focused on miR-26b, which is
a conserved candidate and expressed in multiple human EC types. miR-26b overexpression …
Endothelial cell (EC) proliferation is a crucial event in physiological and pathological angiogenesis. MicroRNAs (miRNAs) have emerged as important modulators of the angiogenic switch. Here we conducted high-content screening of a human miRNA mimic library to identify novel regulators of EC growth systematically. Several miRNAs were nominated that enhanced or inhibited EC growth. Of these, we focused on miR-26b, which is a conserved candidate and expressed in multiple human EC types. miR-26b overexpression enhanced EC proliferation, migration, and tube formation, while inhibition of miR-26b suppressed the proliferative and angiogenic capacity of ECs. A combinatory functional small interfering RNA (siRNA) screening of 48 predicted gene targets revealed that miR-26b enhanced EC growth and survival through inhibiting PTEN expression. Local administration of miR-26b mimics promoted the growth of new microvessels in the Matrigel plug model. In the mouse model of hindlimb ischemia, miR-26b was found to be downregulated in endothelium in the first week following ischemia, and local overexpression of miR-26b improved the survival of capillaries and muscle fibers in ischemic muscles. Our findings suggest that miR-26b enhances EC proliferation, survival, and angiogenesis. miR-26b is a potential target for developing novel pro-angiogenic therapeutics in ischemic disease.
cell.com